W Hiddemann, H C Aul, G Maschmeyer, D Urbanitz, B Lathan, A Reichle, H Köppler, R Donhuijsen-Ant, W D Ludwig, T Grüneisen
{"title":"建议将复发和难治性急性髓性白血病分类,作为顺序应用高剂量与中剂量阿糖胞苷联合米托蒽醌(S-HAM)的随机对照研究的基础。","authors":"W Hiddemann, H C Aul, G Maschmeyer, D Urbanitz, B Lathan, A Reichle, H Köppler, R Donhuijsen-Ant, W D Ludwig, T Grüneisen","doi":"10.1007/978-3-642-74643-7_110","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12936,"journal":{"name":"Haematology and blood transfusion","volume":"33 ","pages":"604-10"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).\",\"authors\":\"W Hiddemann, H C Aul, G Maschmeyer, D Urbanitz, B Lathan, A Reichle, H Köppler, R Donhuijsen-Ant, W D Ludwig, T Grüneisen\",\"doi\":\"10.1007/978-3-642-74643-7_110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12936,\"journal\":{\"name\":\"Haematology and blood transfusion\",\"volume\":\"33 \",\"pages\":\"604-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Haematology and blood transfusion\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/978-3-642-74643-7_110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haematology and blood transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-642-74643-7_110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).